MLYS – mineralys therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Mineralys Therapeutics Provides Corporate Update and Announces Participation in Upcoming LifeSci Partners Corporate Access Event in January 2026
Is It Too Late To Consider Mineralys Therapeutics After Its Huge 2025 Share Price Surge [Yahoo! Finance]
4 Drug, Biotech Stocks Rising More Than 50% in 2025 With Room to Grow [Yahoo! Finance]
Fund Discloses Increased Mineralys Bet Amid 200% Stock Run as New Drug Application Nears [Yahoo! Finance]
Mineralys Therapeutics (NASDAQ:MLYS) was given a new $52.00 price target on by analysts at Stifel Nicolaus. They now have a "buy" rating on the stock.
Form 4 Mineralys Therapeutics, For: Jan 13 Filed by: Rodman David Malcom
Form 144 Mineralys Therapeutics, Filed by: Rodman David Malcom
Form 4 Mineralys Therapeutics, For: Jan 12 Filed by: Levy Adam Scott
Form 4 Mineralys Therapeutics, For: Jan 12 Filed by: Congleton Jon
Form 4 Mineralys Therapeutics, For: Jan 09 Filed by: Rodman David Malcom
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.